InterveXion Awarded $8M to Fund Phase 2 Clinical Study of Anti-Methamphetamine Medication

We are thrilled to have the opportunity to test IXT-m200 in methamphetamine users for the first time”

— Misty Stevens

LITTLE ROCK, AR, USA, October 10, 2017 /EINPresswire.com/ — InterveXion Therapeutics has received a federal grant to fund a second clinical study of IXT-m200, a monoclonal antibody designed to treat methamphetamine abuse. The clinical trial, called STAMPOUT, will be a Phase 2a, parallel-group, placebo-controlled, double-blind study of the effect of IXT-m200 on methamphetamine pharmacokinetics and subjective effects in methamphetamine users. InterveXion has conducted a robust nonclinical evaluation of the pharmacology, toxicology, and pharmacodynamics of IXT-m200, and has completed an initial Phase 1 clinical safety study with this investigational product.

IXT-m200, a monoclonal antibody that specifically binds METH in the blood, is being developed as a pharmacological treatment for use in conjunction with behavioral therapies. IXT-m200 is expected to alter METH pharmacokinetics in human subjects resulting in reduced or blocked subjective effects that reinforce METH use. STAMPOUT, a Phase 2a Study of Antibody for Methamphetamine Outpatient Therapy, will provide proof-of-concept that IXT-m200 can alter METH disposition. This will be the first clinical study in METH users of a biological medication developed specifically for patients with METH use disorders.

“We are thrilled to have the opportunity to test IXT-m200 in methamphetamine users for the first time,” said Misty Stevens, Ph.D., InterveXion’s operations director and co-principal investigator on the grant award. “By showing that an antibody can change the way METH acts and makes a person feel, we will have strong evidence that this type of treatment will work to reduce drug use.”

The three-year $8 million grant award comes from the National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA) which has funded previous developmental studies of IXT-m200. A sub-award to the University of Arkansas for Medical Sciences (UAMS) is part of the grant and funds researchers who are both founders of the company and also prominent UAMS leaders. InterveXion is a BioVentures, LLC company housed on the UAMS campus in Little Rock, AR.

W. Brooks Gentry, M.D., is co-principal investigator on the new grant. He is a professor and chair of the Department of Anesthesiology in the UAMS College of Medicine and InterveXion’s chief medical officer.

InterveXion is a pharmaceutical company whose mission is to discover and advance innovative medications that reduce the impact of human suffering on individuals and communities. Its vision is to be a leader in the development of antagonist therapies that neutralize toxins in the body and thereby improve patient health. InterveXion’s first medications are a monoclonal antibody and an active vaccine for treating methamphetamine abuse. For more information, visit us at www.intervexion.com.

Misty Stevens
InterveXion Therapeutics
501-554-2377
email us here


Source: EIN Presswire

Revolutionary New Treatment of Chronic Lower Extremity Ulcers with LINLINE's Er:YAG Laser Technology

Before and After Treatment with Er:YAG and RecoSMA® Technology

The RecoSMA® system has several lenses that allow the laser beam to be divided into 10,000 microbeams/cm2, with each one of them retaining high power.

Recently published study reveals effective and safe treatment alternative carried out by world renowned experts.

LONDON, UNITED KINGDOM, October 10, 2017 /EINPresswire.com/ — Chronic lower extremity ulcers (CLEU) are very common, have various causes and are difficult to heal. The objective of the prospective study was to analyse the response of CLEU to an Er:YAG 2940 nm laser equipped with unique RecoSMA® technology. Leading experts (1) in the field of laser medicine have now published their evidence in a respected international journal (2).

Evaluation of results achieved was carried out in 18 patients who signed up for the study. The gender distribution was as follows: 16 women and 2 men with an average age of 66. Patients were enrolled in the study by questionnaires, histologies and clinical visual correlation of progress by photographs taken before each session (16 sessions in total), which were then analysed with the help of computer software.

Results after 16 treatment sessions showed complete healing of ulcers or a decrease of their initial area by at least 50% in more than 50% of patients treated. The Student’s t-test and Fisher's exact test were used for the statistical analysis.

LINLINE’s RecoSMA ® technology is unique and used to treat a variety of tissue conditions. It is based on a sophisticated laser optical system, converting the main laser beam into 10,000 microbeams per square cm, which simultaneously interact with the tissue. The powerful mechanical waves from every micro beam scatter from the surface to the deeper layers creating non-thermal partial damage of human cells up to 6 mm in depth. This new technology is unlike any other currently available – the tissue treated undergoes total regeneration, functional restoration, and the promotion of fast neovascularisation. The evidence of the effectiveness of the new RecoSMA® technology is backed up by numerous pre-clinical and clinical studies for aged skin rejuvenation and lifting, correction of scars, treating trophic ulcers and many other applications.

This technology used on difficult CLEU offers an effective treatment alternative. This fast and safe treatment improves, relieves and closes a pathology which is difficult to resolve. Laser treatment is simple to carry out and there is no risk of morbidity, given that no complications were observed during the entire period of this study. To read the full article, follow this link; https://www.jstage.jst.go.jp/article/islsm/26/3/26_17-OR-17/_article

SOURCE: LINLINE Medical Systems SAS

RecoSMA® – Time Back Trigger – #RecoSMA

LINLINE Medical Systems

Founded in 1994 as a research company, LINLINE (http://www.linline.com) is an international manufacturer of high quality medical laser devices for aesthetic, dermatological and surgical purposes.

(1) Alcolea JM, Hernández E, Martínez-Carpio PA, Vélez M, Khomchenko V, Sola A , Trelles MA
(2) https://www.jstage.jst.go.jp/article/islsm/26/3/26_17-OR-17/_article

Richie Hunt
LINLINE Medical Systems
+44 774 732 6762
email us here


Source: EIN Presswire

Paracetamol Market Research 2017- Industry Analysis, Growth, Size, Share, Trends, Forecast to 2022

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, October 10, 2017 /EINPresswire.com/ — Description

This report studies Paracetamol in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Paracetamol Players in each region, with sales, price, revenue and market share for top 5 manufacturer, covering
Mallinckrodt
Anqiu Lu'an
Granules India
Zhejiang Kangle
Farmson
Hebei Jiheng
Novacyl
Anhui BBCA Likang
Anhui Fubore
SKPL
Atabay
Huzhou Konch
Changshu Huagang
Anhui Topsun
Sino Chemical

Request a sample report @ https://www.wiseguyreports.com/sample-request/918130-2017-top-5-paracetamol-east-and-africa

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top 5 players in these regions, from 2012 to 2017 (forecast), like
North America (United States, Canada and Mexico)
Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
Europe (Germany, UK, France, Italy and Russia etc.
South America (Brazil, Chile, Peru and Argentina)
Middle East and Africa (Egypt, South Africa, Saudi Arabia)

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
Powder
Granules

Split by applications, this report focuses on sales, market share and growth rate of Paracetamol in each application, can be divided into
Tablet Drug
Granules Drug
Oral Solution
Others

Complete report details @ https://www.wiseguyreports.com/reports/918130-2017-top-5-paracetamol-east-and-africa

Table of Contents

1 Paracetamol Market Overview
1.1 Product Overview and Scope of Paracetamol
1.2 Paracetamol Segment by Types
1.2.1 Global Sales Market Share of Paracetamol by Types in 2015
1.2.2 Powder
1.2.3 Granules
1.3 Paracetamol Segment by Applications
1.3.1 Paracetamol Consumption Market Share by Applications in 2015
1.3.2 Tablet Drug
1.3.3 Granules Drug
1.3.4 Oral Solution
1.3.5 Others
1.4 Paracetamol Market by Regions
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Asia-Pacific Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 South America Status and Prospect (2012-2022)
1.4.5 Middle East and Africa Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Paracetamol (2012-2022)
2 Global Paracetamol Sales, Revenue (value) and Market Share by Players
2.1 Global Paracetamol Sales and Market Share in 2015 and 2016 by Players
2.2 Global Paracetamol Revenue and Market Share by Players in 2015 and 2016
2.3 Global Paracetamol Average Price by Players in 2015 and 2016
2.4 Global Paracetamol Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Paracetamol Market Competitive Situation and Trends
2.5.1 Paracetamol Market Concentration Rate
2.5.2 Paracetamol Market Share of Top 3 and Top 5 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Global Paracetamol Sales, Revenue (Value) by Regions, Type and Application (2012-2017)
3.1 Global Paracetamol Sales, Revenue and Market Share by Regions (2012-2017)
3.1.1 Global Paracetamol Sales and Market Share by Regions (2012-2017)
3.1.2 Global Paracetamol Revenue and Market Share by Regions (2012-2017)
3.2 Global Paracetamol Sales, Revenue, Market Share and Price by Type (2012-2017)
3.2.1 Global Paracetamol Sales and Market Share by Type (2012-2017)
3.2.2 Global Paracetamol Revenue and Market Share by Type (2012-2017)
3.2.3 Global Paracetamol Price by Type (2012-2017)
3.3 Global Paracetamol Sales and Market Share by Application (2012-2017)
3.4 Global Paracetamol Sales, Revenue, Price and Gross Margin (2012-2017)
4 North America Top 5 Players Paracetamol Sales, Revenue and Price
4.1 North America Top 5 Players Paracetamol Sales, Revenue and Market Share in 2015 and 2016
4.1.1 North America Top 5 Players Paracetamol Sales and Market Share in 2015 and 2016
4.1.2 North America Top 5 Players Paracetamol Revenue and Market Share in 2015 and 2016
4.2 North America Paracetamol Sales, Revenue, Market Share and Price by Type (2012-2017)
4.2.1 North America Paracetamol Sales and Market Share by Type (2012-2017)
4.2.2 North America Paracetamol Revenue and Market Share by Type (2012-2017)
4.2.3 North America Paracetamol Price by Type (2012-2017)
4.3 North America Paracetamol Sales and Market Share by Application (2012-2017)
4.4 North America Paracetamol Sales and Market Share by Country (US, Canada and Mexico) (2012-2017)
4.5 North America Paracetamol Import & Export (2012-2017)
5 Europe Top 5 Players Paracetamol Sales, Revenue and Price
5.1 Europe Top 5 Players Paracetamol Sales, Revenue and Market Share in 2015 and 2016
5.1.1 Europe Top 5 Players Paracetamol Sales and Market Share in 2015 and 2016
5.1.2 Europe Top 5 Players Paracetamol Revenue and Market Share in 2015 and 2016
5.2 Europe Paracetamol Sales, Revenue, Market Share and Price by Type (2012-2017)
5.2.1 Europe Paracetamol Sales and Market Share by Type (2012-2017)
5.2.2 Europe Paracetamol Revenue and Market Share by Type (2012-2017)
5.2.3 Europe Paracetamol Price by Type (2012-2017)
5.3 Europe Paracetamol Sales and Market Share by Application (2012-2017)
5.4 Europe Paracetamol Sales and Market Share by Country (Germany, UK, France, Italy and Russia) (2012-2017)
5.5 Europe Paracetamol Import & Export (2012-2017)
6 Asia-Pacific Top 5 Players Paracetamol Sales, Revenue and Price
6.1 Asia-Pacific Top 5 Players Paracetamol Sales, Revenue and Market Share in 2015 and 2016
6.1.1 Asia-Pacific Top 5 Players Paracetamol Sales and Market Share in 2015 and 2016
6.1.2 Asia-Pacific Top 5 Players Paracetamol Revenue and Market Share in 2015 and 2016
6.2 Asia-Pacific Paracetamol Sales, Revenue, Market Share and Price by Type (2012-2017)
6.2.1 Asia-Pacific Paracetamol Sales and Market Share by Type (2012-2017)
6.2.2 Asia-Pacific Paracetamol Revenue and Market Share by Type (2012-2017)
6.2.3 Asia-Pacific Paracetamol Price by Type (2012-2017)
6.3 Asia-Pacific Paracetamol Sales and Market Share by Application (2012-2017)
6.4 Asia-Pacific Paracetamol Sales and Market Share by Country (China, Japan, Southeast Asia, India and Korea) (2012-2017)
6.5 Asia-Pacific Paracetamol Import & Export (2012-2017)
7 South America Top 5 Players Paracetamol Sales, Revenue and Price
7.1 South America Top 5 Players Paracetamol Sales, Revenue and Market Share in 2015 and 2016
7.1.1 South America Top 5 Players Paracetamol Sales and Market Share in 2015 and 2016
7.1.2 South America Top 5 Players Paracetamol Revenue and Market Share in 2015 and 2016
7.2 South America Paracetamol Sales, Revenue, Market Share and Price by Type (2012-2017)
7.2.1 South America Paracetamol Sales and Market Share by Type (2012-2017)

Continued…

Purchase Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=918130

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Foot and Mouth Disease (FMD) Vaccines Market 2017 Share, Trend, Segmentation and Forecast to 2022

Foot and Mouth Disease (FMD) Vaccines Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022

PUNE, INDIA, October 10, 2017 /EINPresswire.com/ —

Summary

WiseGuyReports.com adds “Foot and Mouth Disease (FMD) Vaccines Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database.

This report provides in depth study of “Foot and Mouth Disease (FMD) Vaccines market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Foot and Mouth Disease (FMD) Vaccines Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Foot and Mouth Disease (FMD) Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
MSD Animal Health
Bayer HealthCare
Sanofi(Merial)
Brilliant Bio Pharma
Agrovet
Inova Biotecnologia Saúde Animal Ltda.
IIL
MEVAC
BVI
VETAL
VSVRI
Biog nesis
VECOL
Limor de Colombia
RVSRI
Cavet Bio
Shen Lian
PVI
CAHIC
Tecon Group
Jinyu Group
China Animal Healthcare

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/884879-global-foot-and-mouth-disease-fmd-vaccines-market-research-report-2017

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
A-Type
O-Type
C-Type
SAT-1 Type
SAT-2 Type
SAT-3 Type
Asia-1 Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines for each application, including
Pig
Cattle
Sheep
Others

At any Query @ https://www.wiseguyreports.com/enquiry/884879-global-foot-and-mouth-disease-fmd-vaccines-market-research-report-2017

Table of Contents

Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2017
1 Foot and Mouth Disease (FMD) Vaccines Market Overview
1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccines
1.2 Foot and Mouth Disease (FMD) Vaccines Segment by Type (Product Category)
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Foot and Mouth Disease (FMD) Vaccines Production Market Share by Type (Product Category) in 2016
1.2.3 A-Type
1.2.4 O-Type
1.2.5 C-Type
1.2.6 SAT-1 Type
1.2.7 SAT-2 Type
1.2.8 SAT-3 Type
1.2.9 Asia-1 Type
1.3 Global Foot and Mouth Disease (FMD) Vaccines Segment by Application
1.3.1 Foot and Mouth Disease (FMD) Vaccines Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Pig
1.3.3 Cattle
1.3.4 Sheep
1.3.5 Others
1.4 Global Foot and Mouth Disease (FMD) Vaccines Market by Region (2012-2022)
1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Foot and Mouth Disease (FMD) Vaccines (2012-2022)
1.5.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue Status and Outlook (2012-2022)
1.5.2 Global Foot and Mouth Disease (FMD) Vaccines Capacity, Production Status and Outlook (2012-2022)

….

7 Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Profiles/Analysis
7.1 MSD Animal Health
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Foot and Mouth Disease (FMD) Vaccines Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Bayer HealthCare
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Foot and Mouth Disease (FMD) Vaccines Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Sanofi(Merial)
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Foot and Mouth Disease (FMD) Vaccines Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Sanofi(Merial) Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Brilliant Bio Pharma
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Foot and Mouth Disease (FMD) Vaccines Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Agrovet
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Foot and Mouth Disease (FMD) Vaccines Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Inova Biotecnologia Saúde Animal Ltda.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Foot and Mouth Disease (FMD) Vaccines Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Inova Biotecnologia Saúde Animal Ltda. Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 IIL
7.8 MEVAC
7.9 BVI
7.10 VETAL
7.11 VSVRI
7.12 Biog nesis
7.13 VECOL
7.14 Limor de Colombia
7.15 RVSRI
7.16 Cavet Bio
7.17 Shen Lian
7.18 PVI
7.19 CAHIC
7.20 Tecon Group
7.21 Jinyu Group
7.22 China Animal Healthcare

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=884879

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Disposable Medical Sensors Market 2017- Global Industry Analysis, Size, Share, Growth, Trends and Forecast by 2022

WiseGuyReports.com adds “Disposable Medical Sensors Market 2017 Global Analysis Research Report Forecasting to 2022”reports to its database.

PUNE, INDIA, October 10, 2017 /EINPresswire.com/ — Disposable Medical Sensors Market:

Executive Summary

Sensors are tools ed in the field of medicine and biotechnology for detection of specific biological, chemical, or physical processes and later transmitting this data. It has become an integral part of medical indtry mainly due to enhanced accuracy, intelligence, capability and reliability reinforced by ongoing technological advancements in the indtry. It has also broadened horizon of diagnostic, surgical, and therapeutic devices in medical indtry. Over the years, global medical indtry has witnessed a paradigm shift with increasing foc on lesser expensive disposable sensor-based devices. Disposable medical devices sensors are handheld or portable scanning devices ed for patient monitoring, diagnostics or therapeutics. It plays a vital role in advancing diagnostic and monitoring methods while leading to overall improvement in quality of healthcare services.

Growth of global disposable medical device sensor market is propelled by rising prevalence of chronic diseases, incidences of hospital acquired infections (HAIs), rising awareness level and favourable government initiatives. However, there are vario factors restraining growth of the market. This includes lack of adequate reimbursement policies which limits widespread adoption of disposable medical sensors and stringent regulations related to manufacturing of sensors. The market is characterized by leading trends such growth in mergers & acquisition activities and innovations in wearable sensors market.

The report “Global Disposable Medical Sensors Market – Placement of Sensors (Wearable, Strip, Ingestible, Implantable, Invasive); Type of Sensors (Biosensors, Image, Pressure, Temperature, Accelerometer); Application of Sensors (Diagnostic, Therapeutic, Patient Monitoring) Market Outlook 2022” provides in-depth analysis of the current scenario, detailed market outlook of the global disposable medical device sensor market with coverage on major market segments such as Placement of Sensors encompassing Wearable, Strip, Ingestible, Implantable and Invasive sensors; Type of Sensors such as Biosensors, Image, Pressure, Temperature and Accelerometer; Application of Sensors encompassing Diagnostic, Therapeutic, Patient Monitoring. Future forecasts of Disposable Medical Sensors Market overall and across vario sub-segments till 2022 is provided in the report. Furthermore, major indtry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major international indtry players operating in the global neurovascular intervention market include Medtronic PLC, GE Healthcare, Philips N.V., Smiths Medical, among others. These players are profiled herein based on attributes such as biness overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on vario parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global disposable medical sensors market.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/2379197-global-disposable-medical-sensors-market-placement-of-sensors-wearable-strip-ingestible

Table of Contents

1. Executive Summary
2. Research Methodology
3. Introduction
3.1 Medical Device Sensor
3.1.1 Disposable Medical Device Sensor
4. Disposable Medical Devices Sensors Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Segmentation
4.2.1 Market Share by Placement of Sensors
4.2.2 Market Share by Application of Sensors
4.2.3 Market Share by Type of Sensors
5. Disposable Medical Devices Sensors Market Segmentation – Placement of Sensors
5.1 Wearable sensors
5.1.1 Overview
5.1.2 Market Sizing (Actual & Forecasted)
5.2 Strip sensors
5.2.1 Overview
5.2.2 Market Sizing (Actual & Forecasted)
5.3 Ingestible sensors
5.3.1 Overview
5.3.2 Market Sizing (Actual & Forecasted)
5.4 Implantable Sensors
5.4.1 Overview
5.4.2 Market Sizing (Actual & Forecasted)
5.5 Invasive sensors
5.5.1 Overview
5.5.2 Market Sizing (Actual & Forecasted)
6. Disposable Medical Devices Sensors Market Segmentation – Type of Sensors
6.1 Biosensors
6.1.1 Overview
6.1.2 Market Sizing (Actual & Forecasted)
6.2 Image Sensors
6.2.1 Overview
6.2.2 Market Sizing (Actual & Forecasted)
6.3 Pressure Sensors
6.3.1 Overview
6.3.2 Market Sizing (Actual & Forecasted)
6.4 Temperature Sensors
6.4.1 Overview
6.4.3 Market Sizing (Actual & Forecasted)
6.5 Accelerometer
6.5.1 Overview
6.5.2 Market Sizing (Actual & Forecasted)
7. Disposable Medical Devices Sensors Market Segmentation – Application
7.1 Diagnostic
7.1.1 Overview
7.1.2 Market Sizing (Actual & Forecasted)
7.2 Therapeutic
7.2.1 Overview
7.2.2 Market Sizing (Actual & Forecasted)
7.3 Patient Monitoring
7.3.1 Overview
7.3.2 Market Sizing (Actual & Forecasted)
8. Market Dynamics
8.1 Indtry Trends & Development
8.1.1 Innovations in Wearable Sensors Market
8.1.2 Mergers & Acquisitions
8.2 Growth Drivers
8.2.1 Prevalence of Chronic Diseases
8.2.2 Increase in Incidences of Hospital Acquired Infections (HAIs)
8.2.3 Rising Awareness Level
8.2.4 Government initiatives
8.3 Challenges
8.3.1 Lack of Reimbursement Policies
8.3.2 Stringent Regulations
9. Competitive Matrix
10. Company Profile
10.1 Medtronic PLC
10.2 GE Healthcare
10.3 Philips N.V.
10.4 Smiths Medical

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2379197

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Electronic Prescription Software Market 2017 Share, Trend, Segmentation and Forecast to 2022

Electronic Prescription Software Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022

PUNE, INDIA, October 10, 2017 /EINPresswire.com/ —

Summary

WiseGuyReports.com adds “Electronic Prescription Software Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database.

This report studies the global Electronic Prescription Software market, analyzes and researches the Electronic Prescription Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Surescripts
Henry Schein
Cerner Corporation
HealthFusion
Allscripts
Athenahealth
Bizmatics
EClinicalWorks
Medi-HER
Practice Fusion
DrFirst

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2369896-global-electronic-prescription-software-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Electronic Prescription Software can be split into
Integrated Systems
Stand-alone Systems

Market segment by Application, Electronic Prescription Software can be split into
Hospitals
Office-based Physicians

At any Query @ https://www.wiseguyreports.com/enquiry/2369896-global-electronic-prescription-software-market-size-status-and-forecast-2022

Table of Contents

Global Electronic Prescription Software Market Size, Status and Forecast 2022
1 Industry Overview of Electronic Prescription Software
1.1 Electronic Prescription Software Market Overview
1.1.1 Electronic Prescription Software Product Scope
1.1.2 Market Status and Outlook
1.2 Global Electronic Prescription Software Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Electronic Prescription Software Market by Type
1.3.1 Integrated Systems
1.3.2 Stand-alone Systems
1.4 Electronic Prescription Software Market by End Users/Application
1.4.1 Hospitals
1.4.2 Office-based Physicians

2 Global Electronic Prescription Software Competition Analysis by Players
2.1 Electronic Prescription Software Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Surescripts
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Henry Schein
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Cerner Corporation
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 HealthFusion
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Allscripts
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Athenahealth
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Bizmatics
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 EClinicalWorks
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Medi-HER
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Practice Fusion
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Electronic Prescription Software Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 DrFirst

4 Global Electronic Prescription Software Market Size by Type and Application (2012-2017)
4.1 Global Electronic Prescription Software Market Size by Type (2012-2017)
4.2 Global Electronic Prescription Software Market Size by Application (2012-2017)
4.3 Potential Application of Electronic Prescription Software in Future
4.4 Top Consumer/End Users of Electronic Prescription Software

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2369896

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Indian Online Pharmaceuticals Market 2017 Industry Key Players, Trends, Sales, Supply, Demand, Analysis,Forecast to 2022

WiseGuyReports.com adds “Online Pharmaceuticals Market 2017 Indian Analysis, Growth, Opportunities Research Report Forecasting to 2022”reports to its database.

PUNE, INDIA, October 10, 2017 /EINPresswire.com/ — Online Pharmaceuticals Market:

Executive Summary

Technological prowess in healthcare indtry has empowered consumers with emergence of E-pharmacy. E-pharmacies can aggregate supplies by having simultaneo access to inventories of multiple pharmacies which leads to availability of hard-to-find medicines at finger click. This has led to phenomenal increase in accessibility of healthcare services to far-flung areas in otherwise ubiquito pharmaceutical indtry in the country. Vario E-pharmacies biness models have been operating in the nation such as Inventory Led model, Hub and Spoke model, Hybrid Model and Local-Channel Model. These models have been analyzed in the report in context to Indian market.

Growth of Indian online pharmaceutical market is propelled by surge in internet penetration, convenience provided to consumers, increasing healthcare awareness, government initiatives and rising disposable incomes. However, there are vario factors restraining growth of the market which includes lack of proper regulatory framework, opposition from offline retailers, high logistics costs and quality assurance issues. The market is characterized by leading trends such investments in E-Pharmacy and online presence of existing “Brick-and-Mortar” drug retailers.

The report “Indian Online Pharmaceuticals Market Outlook 2022” provides in-depth analysis of the current scenario, detailed market outlook of the Indian online pharmacies market with coverage on market regulations, SWOT analysis and biness models existing in the market. Future forecasts of Indian pharmaceuticals market overall and online pharmaceuticals has been provided in the report. Furthermore, major indtry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major indtry players operating Indian online pharmaceuticals market include Apollo Pharmacy, 1MG.com, PM Healthcare and Netmeds.com, among others. These players are profiled herein based on attributes such as biness overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on vario parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data

supported by key market dynamics. This information will be helpful in evaluating opportunities in Indian online pharmaceuticals market.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/2379198-indian-online-pharmaceuticals-market-outlook-2022

Table of Contents

1. Executive Summary
2. Research Methodology
3. Indian Pharmaceutical Market
3.1 Overview
3.2 Pharmaceutical Distribution
3.3 Pharmaceutical Value Chain
3.4 Market Analysis
3.4.1 Market Size by Value (Actual & Forecasted)
3.4.2 Market Share by Segment
4. Online Pharmaceutical
4.1 Introduction
4.1.1 Benefits of Online Pharmaceuticals
4.1.2 Comparison of Offline & Online Pharmacy
4.2 Online Pharmacy- Biness Model
5. Indian Online Pharmacy Market Analysis
5.1 Market Sizing (Actual & Forecasted)
5.2 Market Share by Competitors
6. Market Regulation
7. SWOT Analysis
8. Market Dynamics
8.1 Indtry Trends & Development
8.1.1 Investments in E-Pharmacy
8.1.2 Online Venture of “Brick-and-Mortar” Retailers
8.2 Growth Drivers
8.2.1 Surge in Internet Penetration
8.2.2 Convenience for Consumers
8.2.3 Increasing Healthcare Awareness
8.2.4 Government Initiatives
8.2.5 Rising Disposable Income
8.3 Challenges
8.3.1 Lack of Proper Regulatory Framework
8.3.2 Opposition from Offline Retailers
8.3.3 High Logistics Cost
8.3.4 Quality Assurance Issues
9. Competitive Landscape
10. Company Profiles
10.1 Apollo Pharmacy
10.2 1MG.com
10.3 PM Healthcare
10.4 Netmeds.com
11. Recommendations

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2379198

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Life Science Software Market 2017 Segmentation, Demand, Growth, Trend, Opportunity and Forecast to 2022

Life Science Software-Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022

PUNE, INDIA, October 10, 2017 /EINPresswire.com/ — Life Science Software Market 2017   

Description: 

This report studies the global Life Science Software market, analyzes and researches the Life Science Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like 
Medidata Solutions 
Oracle 
SAP 
SAS Institute 
Veeva Systems 
ArisGlobal 
DXC technology 
EPAM Systems 
FUJITSU 
HCL Technologies 
Instem Group of Companies 
PDS 
Persistent Systems

Request for Sample Report@ https://www.wiseguyreports.com/sample-request/2369908-global-life-science-software-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers 
United States 
EU 
Japan 
China 
India 
Southeast Asia

Market segment by Type, Life Science Software can be split into 
Cloud-based 
On-premises

Market segment by Application, Life Science Software can be split into 
Pharmaceuticals 
Biotechnology

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/2369908-global-life-science-software-market-size-status-and-forecast-2022

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents:

Global Life Science Software Market Size, Status and Forecast 2022 
1 Industry Overview of Life Science Software 
1.1 Life Science Software Market Overview 
1.1.1 Life Science Software Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Life Science Software Market Size and Analysis by Regions 
1.2.1 United States 
1.2.2 EU 
1.2.3 Japan 
1.2.4 China 
1.2.5 India 
1.2.6 Southeast Asia 
1.3 Life Science Software Market by Type 
1.3.1 Cloud-based 
1.3.2 On-premises 
1.4 Life Science Software Market by End Users/Application 
1.4.1 Pharmaceuticals 
1.4.2 Biotechnology

2 Global Life Science Software Competition Analysis by Players 
2.1 Life Science Software Market Size (Value) by Players (2016 and 2017) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

 …….

3 Company (Top Players) Profiles 
3.1 Medidata Solutions 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Life Science Software Revenue (Value) (2012-2017) 
3.1.5 Recent Developments 
3.2 Oracle 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Life Science Software Revenue (Value) (2012-2017) 
3.2.5 Recent Developments 
3.3 SAP 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Life Science Software Revenue (Value) (2012-2017) 
3.3.5 Recent Developments 
3.4 SAS Institute 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Life Science Software Revenue (Value) (2012-2017) 
3.4.5 Recent Developments 
3.5 Veeva Systems 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Life Science Software Revenue (Value) (2012-2017) 
3.5.5 Recent Developments 
3.6 ArisGlobal 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Life Science Software Revenue (Value) (2012-2017) 
3.6.5 Recent Developments 
3.7 DXC technology 
3.7.1 Company Profile 
3.7.2 Main Business/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Life Science Software Revenue (Value) (2012-2017) 
3.7.5 Recent Developments 
3.8 EPAM Systems 
3.8.1 Company Profile 
3.8.2 Main Business/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Life Science Software Revenue (Value) (2012-2017) 
3.8.5 Recent Developments 
3.9 FUJITSU 
3.9.1 Company Profile 
3.9.2 Main Business/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Life Science Software Revenue (Value) (2012-2017) 
3.9.5 Recent Developments 
3.10 HCL Technologies 
3.10.1 Company Profile 
3.10.2 Main Business/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 Life Science Software Revenue (Value) (2012-2017) 
3.10.5 Recent Developments 
3.11 Instem Group of Companies 
3.12 PDS 
3.13 Persistent Systems

Continued…..

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2369908

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

E-Prescribing Software Market 2017 Global Industry Key Players, Share, Trend, Segmentation and Forecast to 2022

E-Prescribing Software Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022

PUNE, INDIA, October 10, 2017 /EINPresswire.com/ — E-Prescribing Software Market 2017

Wiseguyreports.Com adds “E-Prescribing Software Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Report Details:

This report provides in depth study of “E-Prescribing Software Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The E-Prescribing Software Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global E-Prescribing Software market, analyzes and researches the E-Prescribing Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

This report focuses on the top players in global market, like 
Surescripts 
Henry Schein 
Cerner Corporation 
HealthFusion 
Allscripts 
Athenahealth 
Bizmatics 
EClinicalWorks 
Medi-HER 
Practice Fusion 
DrFirst

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2369892-global-e-prescribing-software-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers 
United States 
EU 
Japan 
China 
India 
Southeast Asia

Market segment by Type, E-Prescribing Software can be split into 
Integrated Systems 
Stand-alone Systems

Market segment by Application, E-Prescribing Software can be split into 
Hospitals 
Office-based Physicians

Complete Report Details@ https://www.wiseguyreports.com/reports/2369892-global-e-prescribing-software-market-size-status-and-forecast-2022

Major Key Points in Table of Content:

Global E-Prescribing Software Market Size, Status and Forecast 2022 
1 Industry Overview of E-Prescribing Software 
1.1 E-Prescribing Software Market Overview 
1.1.1 E-Prescribing Software Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global E-Prescribing Software Market Size and Analysis by Regions 
1.2.1 United States 
1.2.2 EU 
1.2.3 Japan 
1.2.4 China 
1.2.5 India 
1.2.6 Southeast Asia 
1.3 E-Prescribing Software Market by Type 
1.3.1 Integrated Systems 
1.3.2 Stand-alone Systems 
1.4 E-Prescribing Software Market by End Users/Application 
1.4.1 Hospitals 
1.4.2 Office-based Physicians

2 Global E-Prescribing Software Competition Analysis by Players 
2.1 E-Prescribing Software Market Size (Value) by Players (2016 and 2017) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 
3.1 Surescripts 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.1.5 Recent Developments 
3.2 Henry Schein 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.2.5 Recent Developments 
3.3 Cerner Corporation 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.3.5 Recent Developments 
3.4 HealthFusion 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.4.5 Recent Developments 
3.5 Allscripts 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.5.5 Recent Developments 
3.6 Athenahealth 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.6.5 Recent Developments 
3.7 Bizmatics 
3.7.1 Company Profile 
3.7.2 Main Business/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.7.5 Recent Developments 
3.8 EClinicalWorks 
3.8.1 Company Profile 
3.8.2 Main Business/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.8.5 Recent Developments 
3.9 Medi-HER 
3.9.1 Company Profile 
3.9.2 Main Business/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.9.5 Recent Developments 
3.10 Practice Fusion 
3.10.1 Company Profile 
3.10.2 Main Business/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 E-Prescribing Software Revenue (Value) (2012-2017) 
3.10.5 Recent Developments 

Continued….

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2369892

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Cosmetics Preservative Market 2017 Segmentation, Demand, Growth, Trend, Opportunity and Forecast to 2022

Cosmetics Preservative Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022

PUNE, INDIA, October 10, 2017 /EINPresswire.com/ —

Summary

WiseGuyReports.com adds “Cosmetics Preservative Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database.

This report provides in depth study of “Cosmetics Preservative market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Cosmetics Preservative Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies Cosmetics Preservative in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Dow Chemicals
Lonza Group
BASF
Clariant
Symrise AG
Chemipol
Brenntag AG
Ashland

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2333496-global-cosmetics-preservative-market-professional-survey-report-2017

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Phenol Derivatives
Formaldehyde
Organic Acids
Other

By Application, the market can be split into
Sunscreens
Lotions
Antiaging
Haircare

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

At any Query @ https://www.wiseguyreports.com/enquiry/2333496-global-cosmetics-preservative-market-professional-survey-report-2017

Table of Contents

Global Cosmetics Preservative Market Professional Survey Report 2017
1 Industry Overview of Cosmetics Preservative
1.1 Definition and Specifications of Cosmetics Preservative
1.1.1 Definition of Cosmetics Preservative
1.1.2 Specifications of Cosmetics Preservative
1.2 Classification of Cosmetics Preservative
1.2.1 Phenol Derivatives
1.2.2 Formaldehyde
1.2.3 Organic Acids
1.2.4 Other
1.3 Applications of Cosmetics Preservative
1.3.1 Sunscreens
1.3.2 Lotions
1.3.3 Antiaging
1.3.4 Haircare
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Cosmetics Preservative
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cosmetics Preservative
2.3 Manufacturing Process Analysis of Cosmetics Preservative
2.4 Industry Chain Structure of Cosmetics Preservative

….

8 Major Manufacturers Analysis of Cosmetics Preservative
8.1 Dow Chemicals
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Dow Chemicals 2016 Cosmetics Preservative Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Dow Chemicals 2016 Cosmetics Preservative Business Region Distribution Analysis
8.2 Lonza Group
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Lonza Group 2016 Cosmetics Preservative Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Lonza Group 2016 Cosmetics Preservative Business Region Distribution Analysis
8.3 BASF
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 BASF 2016 Cosmetics Preservative Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 BASF 2016 Cosmetics Preservative Business Region Distribution Analysis
8.4 Clariant
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Clariant 2016 Cosmetics Preservative Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Clariant 2016 Cosmetics Preservative Business Region Distribution Analysis
8.5 Symrise AG
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Symrise AG 2016 Cosmetics Preservative Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Symrise AG 2016 Cosmetics Preservative Business Region Distribution Analysis
8.6 Chemipol
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Chemipol 2016 Cosmetics Preservative Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Chemipol 2016 Cosmetics Preservative Business Region Distribution Analysis
8.7 Brenntag AG
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Brenntag AG 2016 Cosmetics Preservative Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Brenntag AG 2016 Cosmetics Preservative Business Region Distribution Analysis
8.8 Ashland
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Ashland 2016 Cosmetics Preservative Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Ashland 2016 Cosmetics Preservative Business Region Distribution Analysis

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2333496

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire